We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

MorphoSys and Boehringer Ingelheim Expand Collaboration with Cancer-Related Antibody Program

News   Nov 13, 2006

 
MorphoSys and Boehringer Ingelheim Expand Collaboration with Cancer-Related Antibody Program
 
 
Advertisement
 

RELATED ARTICLES

Washington University COVID-19 Vaccine Effective in Mice

News

An experimental vaccine is effective at preventing pneumonia in mice infected with the COVID-19 virus, according to a study from Washington University School of Medicine in St. Louis

READ MORE

Lowering the Levels of Key Protein Might Be a Novel Way To Treat MS

News

In an animal model of multiple sclerosis, decreasing the amount of a protein made in the liver significantly protected against the development of key symptoms and promoted recovery.

READ MORE

Insights Into How Zika Virus Suppresses the Host Immune System

News

A research team has outlined how the Zika virus, which constituted an epidemic threat in 2016, suppresses the immune system of its host.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE